Market Access Views & Analysis

Views & Analysis

Market Access

Why impactful and scalable global Medical Information (MI) p...

A trusted MI partner ensures compliance with global and local regulations and provides consistent access to accurate medical information.

Market Access

neurotech representation of head in code

Neurotech patents in Europe: Methods, medical devices, and t...

The field of neurotechnology is rapidly evolving, bringing together advances in neuroscience, engineering, materials science, and computing.

Market Access

Early strategic evidence planning is a key success factor in...

As the European Union (EU) ushers in a new era of health technology regulation, pharmaceutical companies face both unprecedented challenges and opportunities.

Market Access

pharmaphorum Episode 200a - Suzanne Aitken, Clinigen

MAPs, EAPs, and patient access: Suzanne Aitken on the challe...

Suzanne Aitken, SVP of managed access at Clinigen, discussing the role of managed access programmes in the current pharmaceutical landscape.

Market Access

Biotech ≠ tech: Why venture capital needs a new playbook for...

Silicon Valley investors have been conditioned by two decades of software: launch quickly, capture users faster, and hit the magic $1 million ARR mark within about three years,1

Market Access

Capital efficient trials in a time of economic uncertainty

In the current climate of capital constraints, tariffs, and policy uncertainty, as well as changing regulatory dynamics, pharma and biotech companies should address not just whether a trial

Why impactful and scalable global Medical Information (MI) p...

Neurotech patents in Europe: Methods, medical devices, and t...

Early strategic evidence planning is a key success factor in...

MAPs, EAPs, and patient access: Suzanne Aitken on the challe...

Biotech ≠ tech: Why venture capital needs a new playbook for...

Capital efficient trials in a time of economic uncertainty

CHMP decision levels the playing field for GSK's RSV jab

How to meet your physicians where they are online

Views & Analysis

Editor's Picks